Breakthrough candidemia in children: Clinical and microbiological characteristics, therapeutic strategies and impact on outcomes

Mei Yin Lai, Jen Fu Hsu, Shih Ming Chu, I. Hsyuan Wu, Hsuan Rong Huang, Chun Chih Lin, I-Ta Lee, Ming Chou Chiang, Ren Huei Fu, Ming Horng Tsai

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: To assess the characteristics, treatments, risk factors and outcomes of breakthrough candidemia in children. Materials & methods: Episodes of breakthrough candidemia in children were compared with the remaining episodes in a 13-year cohort study. Results: Out of 319 episodes, 45 (14.1%) were breakthrough candidemia. Breakthrough candidemia occurred in patients with more acutely ill conditions, and the majority was caused by non-albicans Candida species (73.3%; 33 episodes). A total of 79.1% of breakthrough candidemia were caused by antifungal-susceptible Candida isolates and emergence of resistance was the mechanism in five cases of patients receiving fluconazole. Episodes of breakthrough candidemia had significantly higher illness severity and higher rates of fungemia-attributable mortality. Conclusion: Breakthrough candidemia independently contributed to unfavorable outcomes, and more aggressive treatment strategies are warranted when breakthrough candidemia is encountered.

Original languageEnglish
Pages (from-to)695-705
Number of pages11
JournalFuture Microbiology
Volume12
Issue number8
DOIs
Publication statusPublished - Jun 1 2017
Externally publishedYes

Fingerprint

Candidemia
Therapeutics
Candida
Fungemia
Fluconazole
Cohort Studies
Mortality

Keywords

  • antifungal susceptibility
  • bloodstream infection
  • candidemia
  • invasive candidiasis
  • mortality

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Breakthrough candidemia in children : Clinical and microbiological characteristics, therapeutic strategies and impact on outcomes. / Lai, Mei Yin; Hsu, Jen Fu; Chu, Shih Ming; Wu, I. Hsyuan; Huang, Hsuan Rong; Lin, Chun Chih; Lee, I-Ta; Chiang, Ming Chou; Fu, Ren Huei; Tsai, Ming Horng.

In: Future Microbiology, Vol. 12, No. 8, 01.06.2017, p. 695-705.

Research output: Contribution to journalArticle

Lai, Mei Yin ; Hsu, Jen Fu ; Chu, Shih Ming ; Wu, I. Hsyuan ; Huang, Hsuan Rong ; Lin, Chun Chih ; Lee, I-Ta ; Chiang, Ming Chou ; Fu, Ren Huei ; Tsai, Ming Horng. / Breakthrough candidemia in children : Clinical and microbiological characteristics, therapeutic strategies and impact on outcomes. In: Future Microbiology. 2017 ; Vol. 12, No. 8. pp. 695-705.
@article{6c157ef2b5664aa48ec0151590e946bf,
title = "Breakthrough candidemia in children: Clinical and microbiological characteristics, therapeutic strategies and impact on outcomes",
abstract = "Aim: To assess the characteristics, treatments, risk factors and outcomes of breakthrough candidemia in children. Materials & methods: Episodes of breakthrough candidemia in children were compared with the remaining episodes in a 13-year cohort study. Results: Out of 319 episodes, 45 (14.1{\%}) were breakthrough candidemia. Breakthrough candidemia occurred in patients with more acutely ill conditions, and the majority was caused by non-albicans Candida species (73.3{\%}; 33 episodes). A total of 79.1{\%} of breakthrough candidemia were caused by antifungal-susceptible Candida isolates and emergence of resistance was the mechanism in five cases of patients receiving fluconazole. Episodes of breakthrough candidemia had significantly higher illness severity and higher rates of fungemia-attributable mortality. Conclusion: Breakthrough candidemia independently contributed to unfavorable outcomes, and more aggressive treatment strategies are warranted when breakthrough candidemia is encountered.",
keywords = "antifungal susceptibility, bloodstream infection, candidemia, invasive candidiasis, mortality",
author = "Lai, {Mei Yin} and Hsu, {Jen Fu} and Chu, {Shih Ming} and Wu, {I. Hsyuan} and Huang, {Hsuan Rong} and Lin, {Chun Chih} and I-Ta Lee and Chiang, {Ming Chou} and Fu, {Ren Huei} and Tsai, {Ming Horng}",
year = "2017",
month = "6",
day = "1",
doi = "10.2217/fmb-2016-0223",
language = "English",
volume = "12",
pages = "695--705",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "8",

}

TY - JOUR

T1 - Breakthrough candidemia in children

T2 - Clinical and microbiological characteristics, therapeutic strategies and impact on outcomes

AU - Lai, Mei Yin

AU - Hsu, Jen Fu

AU - Chu, Shih Ming

AU - Wu, I. Hsyuan

AU - Huang, Hsuan Rong

AU - Lin, Chun Chih

AU - Lee, I-Ta

AU - Chiang, Ming Chou

AU - Fu, Ren Huei

AU - Tsai, Ming Horng

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Aim: To assess the characteristics, treatments, risk factors and outcomes of breakthrough candidemia in children. Materials & methods: Episodes of breakthrough candidemia in children were compared with the remaining episodes in a 13-year cohort study. Results: Out of 319 episodes, 45 (14.1%) were breakthrough candidemia. Breakthrough candidemia occurred in patients with more acutely ill conditions, and the majority was caused by non-albicans Candida species (73.3%; 33 episodes). A total of 79.1% of breakthrough candidemia were caused by antifungal-susceptible Candida isolates and emergence of resistance was the mechanism in five cases of patients receiving fluconazole. Episodes of breakthrough candidemia had significantly higher illness severity and higher rates of fungemia-attributable mortality. Conclusion: Breakthrough candidemia independently contributed to unfavorable outcomes, and more aggressive treatment strategies are warranted when breakthrough candidemia is encountered.

AB - Aim: To assess the characteristics, treatments, risk factors and outcomes of breakthrough candidemia in children. Materials & methods: Episodes of breakthrough candidemia in children were compared with the remaining episodes in a 13-year cohort study. Results: Out of 319 episodes, 45 (14.1%) were breakthrough candidemia. Breakthrough candidemia occurred in patients with more acutely ill conditions, and the majority was caused by non-albicans Candida species (73.3%; 33 episodes). A total of 79.1% of breakthrough candidemia were caused by antifungal-susceptible Candida isolates and emergence of resistance was the mechanism in five cases of patients receiving fluconazole. Episodes of breakthrough candidemia had significantly higher illness severity and higher rates of fungemia-attributable mortality. Conclusion: Breakthrough candidemia independently contributed to unfavorable outcomes, and more aggressive treatment strategies are warranted when breakthrough candidemia is encountered.

KW - antifungal susceptibility

KW - bloodstream infection

KW - candidemia

KW - invasive candidiasis

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=85022227691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022227691&partnerID=8YFLogxK

U2 - 10.2217/fmb-2016-0223

DO - 10.2217/fmb-2016-0223

M3 - Article

C2 - 28326813

AN - SCOPUS:85022227691

VL - 12

SP - 695

EP - 705

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 8

ER -